Ted Halmos

Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061

Montse Llinàs‐Brunet, Murray D. Bailey, Gordon T. Bolger et al. · Journal of Medicinal Chemistry · 2004 · 186 citations

Competitive Hexapeptide Inhibitors, Pharmacotherapy, Antiviral Drug +16

Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1

Lee D. Fader, Éric Malenfant, Mathieu Parisien et al. · ACS Medicinal Chemistry Letters · 2014 · 175 citations · Full text

Hiv-1 Integrase, Immunology, Molecular Biology +16

Peptide-based inhibitors of the hepatitis C virus serine protease

Montse Llinàs‐Brunet, Murray D. Bailey, Gulrez Fazal et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 162 citations · Full text

Biochemistry, Natural Sciences, Antiviral Drug Development +7

A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease:  Discovery of Potent and Specific Tripeptide Inhibitors

Montse Llinàs‐Brunet, Murray D. Bailey, Élise Ghiro et al. · Journal of Medicinal Chemistry · 2004 · 122 citations · Full text

Peptide Substrates, Antiviral Drug, Chemical Biology +21

Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors

Montse Llinàs‐Brunet, Murray D. Bailey, Gulrez Fazal et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 108 citations · Full text

Biochemistry, Medicine, Antiviral Drug Development +9